By analyzing gene expression data and clinical data from public databases, we found that TASL expression was higher in LGG and GBM tissues than in normal brain tissues (Figs. 1A and 6D), and high TASL expression was positively associated with shorter survival in glioma patients (Figs. 4E and 5), and high TASL expression was also a poor independent prognostic factor in LGG patients. Here, TASL is linked to glioma.